As the leading cause of death in Europe and soon worldwide, cancer is a challenge for human intelligence. The “Artificial Intelligence & Cancer” project aims to position France as a focal point of industrial interests in Europe and above all focuses on the emergence of new solutions for the benefit of patients.
This project focuses on federating public and private stakeholders around a national initiative that will benefit the overall ecosystem for innovation in oncology and that will help develop innovative diagnostic and therapeutic solutions to address needs that are currently unmet in cancer care.
The approach is very practical and based on the analysis of public and private cancer data for medical and industrial issues. These issues are organized in projects called Cancer Research Projects (CRP).
Thus, this project aims to modernize and differentiate the ecosystem for national cancer data by supporting its attractiveness in Europe and worldwide and allowing all stakeholders (public research, patients, startups and biotech companies) to have access to the benefits of the investments made.
Co-built on a unique public-private partnership, the “AI & Cancer” project is notably based on the expertise of ARIIS, pharmaceutical companies and the National Institute for Cancer.
The “AI & Cancer” project aims to :
ARIIS and France Biotech are joining forces for the “Biomarkers for Value” event on May 10, 2021! ARIIS and France Biotech, with the support of health competitiveness clusters, are organizing a day on biomarker issues on May 10, 2021 in order to raise biotechs’ awareness of the issues and challenges...
En savoir plusThe taskforce “Use of real-world data in decision making” presents its recommendations! Set up as part of the Strategic Contract for the Healthcare Industry and Health Technologies sectors, which was signed on 04 February 2019, the taskforce “Use of real-world data in decision making” presents now its recommendations. Co-led by Laurie Lévy-Bachelot...
En savoir plusFeedback on the «HYBRID 2021» event : a full digital experience to promote French research abroad For the first time, ARIIS, AVIESAN, Leem, Bpifrance and France Biotech have joined forces to create a new event, HYBRID, which was held on March 16-17, 2021. As a result of a merger between...
En savoir plus